Websites Hosted in dnadns3e.gene.com Nameserver
The Nameserver dnadns3e.gene.com have a IP Address of 72.34.133.50 which is hosted on United States of America.
Genentech
Breakthrough science. One moment, one day, one person at a time.
Not Applicable
$
8.95
Genentech
Breakthrough science. One moment, one day, one person at a time.
Not Applicable
$
8.95
Genentech
Breakthrough science. One moment, one day, one person at a time.
Not Applicable
$
8.95
Genentech
Breakthrough science. One moment, one day, one person at a time.
Not Applicable
$
8.95
Prescription Flu Treatment | XOFLUZA™ (baloxavir marboxil)
Learn about XOFLUZA™ (baloxavir marboxil), a one-dose prescription medicine used to treat the flu. See full safety for more information.
Not Applicable
$
8.95
Prescription Flu Treatment | XOFLUZA™ (baloxavir marboxil)
Learn about XOFLUZA™ (baloxavir marboxil), a one-dose prescription medicine used to treat the flu. See full safety for more information.
Not Applicable
$
8.95
OCREVUS® (ocrelizumab) for Relapsing MS and Primary Progressive MS
Learn about OCREVUS® (ocrelizumab), a prescription medicine used to treat adults with relapsing or primary progressive multiple sclerosis. See full safety for more information.
Not Applicable
$
8.95
OCREVUS® (ocrelizumab) for Relapsing MS and Primary Progressive MS
Learn about OCREVUS® (ocrelizumab), a prescription medicine used to treat adults with relapsing or primary progressive multiple sclerosis. See full safety for more information.
Not Applicable
$
8.95
Genentech: 404 Page Not Found
Breakthrough science. One moment, one day, one person at a time.
Not Applicable
$
8.95
PD-L1 + VEGF Pathway Inhibition | BioOncology
Discover how VEGF can stimulate angiogenesis and prevent T-cell infiltration, and how PD-L1 + VEGF inhibition may restore the cancer immunity cycle.
Not Applicable
$
8.95
LUCENTIS®: Wet AMD, DR, DME, mCNV & RVO Treatment Option
Learn about LUCENTIS (ranibizumab injection), a treatment option for wet AMD, diabetic macular edema (DME), diabetic retinopathy (DR), mCNV, & RVO. See full safety for more information.
Not Applicable
$
8.95
Roche - Doing now what patients need next
As a pioneer in healthcare, we have been committed to improving lives since the company was founded in 1896 in Basel, Switzerland. Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally.
Not Applicable
$
8.95
Roche - Doing now what patients need next
As a pioneer in healthcare, we have been committed to improving lives since the company was founded in 1896 in Basel, Switzerland. Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally.
Not Applicable
$
8.95
Patient Stories | HEMLIBRA® (emicizumab-kxwh)
Hear stories from patients and caregivers about their experience with HEMLIBRA® (emicizumab-kxwh) treatment. See full safety and BOXED WARNING.
Not Applicable
$
8.95
HER2+ Breast Cancer Treatment Option | PERJETA® (pertuzumab)
Discover PERJETA® (pertuzumab), in combination with Herceptin® (trastuzumab) and chemotherapy for patients with HER2+ early breast cancer that has a high likelihood of coming back. See full safety for more information.
Not Applicable
$
8.95
Sign-Up for Support | HEMLIBRA® (emicizumab-kxwh)
Discover how you can sign‐up to receive HEMLIBRA® (emicizumab‐kxwh) support and information sent directly to your email. See full safety and BOXED WARNING.
Not Applicable
$
8.95
Avastin® (bevacizumab) Efficacy Data, Dosing, & Prescribing Informatio
Learn about Avastin® (bevacizumab) for FDA approved indications. Avastin is indicated for the treatment of glioblastoma as a single agent for adult patients with progressive disease following prior therapy. The effectiveness of Avastin in glioblastoma is based on an improvement in objective response rate. There are no
3,406,582
$
240.00
HER2+ Cancer Treatment Option | Herceptin® (trastuzumab)
Find information about Herceptin®, a treatment for Early and Metastatic Breast Cancer and Stomach/GEJ Cancer. See full safety & Boxed Warnings for more information.
Not Applicable
$
8.95
Genentech Forum | Managed Care Resources
Find helpful resources for managed care and health system decision makers from Genentech, including oncology cost containment trends and care management workshops.
Not Applicable
$
8.95
